Research reveals new aspect of platelet behavior in heart attacks: Clots can sense blood flow

The microfluidic device the research team used to observe the flow-dependent clotting behavior.

The disease atherosclerosis involves the build up of fatty tissue within arterial walls, creating unstable structures known as plaques. These plaques grow until they burst, rupturing the wall and causing the formation of a blood clot within the artery. These clots also grow until they block blood flow; in the case of the coronary artery, this can cause a heart attack.

New research from the University of Pennsylvania has shown that clots forming under arterial-flow conditions have an unexpected ability to sense the surrounding blood moving over it.  If the flow stops, the clot senses the decrease in flow and this triggers a contraction similar to that of a muscle. The contraction squeezes out water, making the clot denser.

Better understanding of the clotting dynamics that occur in , as opposed to the dynamics at play in closing a wound, could lead to more effective drugs for prevention. 

The research was conducted by graduate student Ryan Muthard and Scott Diamond, professor and chair of the Department of Chemical and Biomolecular Engineering in the School of Engineering and Applied Science. 

Their work was published in the journal Arteriosclerosis, and , which is published by the .

"Researchers have known for decades that blood sitting in a test tube will clot and then contract to squeeze out water," Muthard said.  "Yet clots observed inside injured mouse blood vessels don't display much contractile activity.  We never knew how to reconcile these two studies, until an unexpected observation in the lab."

Using a specially designed microfluidic device, the researchers pulsed fluorescent dye across a clot to investigate how well it blocked bleeding. When they stopped the flow in order to adjust a valve to deliver the dye, the researchers were startled to see that a massive contraction was triggered in the clot. If they delivered the dye without stopping flow, there was no change in the clot properties.

"We think this may be one of the fundamental differences between clots formed inside blood vessels that cause thrombosis and clots formed when blood slowly pools around a leaking blood vessel during a bleeding event," Diamond said. "The flow sensing alters the clot mechanics." 

To investigate this alteration, the researchers used an intracellular fluorescent dye that binds to calcium. They found that when the flow stops, the platelets' calcium levels increase and they become activated. By adding drugs that block ADP and thromboxane, chemicals involved in the clotting process, the researchers were able to prevent this platelet calcium mobilization and stop the contraction.   

Millions of patients already take drugs that target these chemical pathways: P2Y12 inhibitors, such as Plavix, block ADP signaling in platelets, and aspirin blocks platelets' synthesis of thromboxane. This discovery suggests that these drugs may be interfering with contractile mechanisms that are triggered when ADP and thromboxane become elevated, such as when the flow around the clot decreases or stops.  Beyond slowing the growth of clots, these anti-platelet drugs may also be altering the mechanics of the clot by preventing contraction. 

"It is an example of 'quorum sensing' by the platelets in the clots," Diamond said. "The platelets are sensing each other and the prevailing environment. This causes them to release ADP and thromboxane, but it is rapidly diluted away by the surrounding

"However, when the flow over the clot decreases or stops, the ADP and thromboxane levels rapidly build up, and this drives platelet ," Diamond said.

More information: atvb.ahajournals.org/content/e… 75-adab-e9be5b4ba202

add to favorites email to friend print save as pdf

Related Stories

Scientists develop large-scale simulation of human blood

May 01, 2012

(Medical Xpress) -- Having a virtual copy of a patient’s blood in a computer would be a boon to researchers and doctors. They could examine a simulated heart attack caused by blood clotting in a diseased ...

Blood cell breakthrough could help treat heart disease

Apr 27, 2012

(Phys.org) -- Scientists at the University of Reading have made a groundbreaking discovery into the way blood clots are formed, potentially leading to the development of new drugs to treat one of the world's ...

How life-threatening blood clots take hold

Apr 16, 2009

When plaques coating blood vessel walls rupture and expose collagen, platelets spring into action to form a blood clot at the damaged site. Now, a new report in the April 17th issue of the journal Cell, a Cell Press public ...

Recommended for you

A novel therapy for sepsis?

2 hours ago

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

Cellular protein may be key to longevity

Sep 15, 2014

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions ...

Gut bacteria tire out T cells

Sep 15, 2014

Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Me ...

User comments